Responsible antibiotic manufacturing: Future of pharma sustainability
According to Courtney Soulsby, AMR continues to threaten global population health, particularly across India. An opportunity to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Reimagining healthcare professionals engagement with omnichannel experiences
By Akash Kedia, MD and Lead – Life Sciences, Accenture in India and
Vinita Vasanth, MD and Commercial Lead - Life Sciences,…
Glenmark launches the next phase of ‘India First Heart First’ Campaign
The initial phase of the campaign kicked off with an event on World Heart Day on September 29, 2023. The initiative seeks to…
Growth Guardians | Sailesh Sigatapu, General Partner at Anthill Ventures
Growth Guardian I Express Pharma – Nutrify Today Boardroom Series | Special Edition
GVSAP collaborates with Biocytogen
Reportedly, the alliance aims to accelerate innovation in the biopharmaceutical industry
Biogen, Ionis terminates development of ALS investigational drug
Topline results from the Phase 1/2 ALSpire study indicated no reduction in levels of plasma neurofilament light chain (NfL), a…
GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData
According to GlobalData, more than 190 million people currently live with type 2 diabetes and/or obesity in 7MM, and the numbers…
Glenmark receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution,…
Glenmark’s Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% has been determined by the FDA to be…
SII invests in IntegriMedical’s Needle-Free Injection System technology
With this investment, SII will acquire a 20 per cent stake in IntegriMedical. Reportedly, the investment is expected to accelerate…
Zydus, MSN partner to license and supply Cabozantinib Tablets for the US
As per the agreement, MSN will manufacture and supply the generic version of CABOMETYX and Zydus will exclusively market,…